Biogen reported $491.5M in Trade Creditors for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US USD 12.75M 2.74M
Bayer BAYN:GR EUR 7.55B 996M
Biogen BIIB:US USD 491.5M 108.3M
Bluebird Bio BLUE:US USD 18.62M 6.24M
Esperion Therapeutics ESPR:US USD 23.04M 4.46M
Intercept Pharmaceuticals ICPT:US USD 14.23M 7.07M
Intra Cellular Therapies ITCI:US USD 10.4M 3.82M
Marinus Pharmaceuticals MRNS:US USD 4.46M 2.84M
Moderna Inc MRNA:US USD 487M 157M
Novartis NOVN:VX USD 5.15B 453M
Ptc Therapeutics PTCT:US USD 27.27M 6.41M
Puma Biotechnology PBYI:US USD 6.44M 8.49M
Sangamo Biosciences SGMO:US USD 22.42M 5.04M
Sarepta Therapeutics SRPT:US USD 95.88M 22.59M
Seattle Genetics SGEN:US USD 207.85M 63.35M
Teva Pharmaceutical TEVA:IT USD 1.89B 252M
Ultragenyx Pharmaceutical RARE:US USD 43.27M 19.74M
YTE INCY:US USD 277.55M 114.37M